These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25790226)

  • 1. Eculizumab for aHUS post-transplantation: when and how to stop a good thing.
    Masengu A; Courtney A
    Transpl Int; 2015 Aug; 28(8):1000-1. PubMed ID: 25790226
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Renal Transplantation in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab in China.
    Sun ZJ; Du X; Su LL; Zhang XD; Wang Y; Ren L; Wang W
    Chin Med J (Engl); 2016 Jun; 129(11):1379-81. PubMed ID: 27231180
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A; Hughes P; Szer J; Tuckfield A; Van Eps C; Cambell SB; Hawley C; Burke J; Kausman J; Hewitt I; Parnham A; Ford S; Isbel N
    Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
    Ranch D; Crowther B; Arar M; Assanasen C
    Pediatr Transplant; 2014 Sep; 18(6):E185-9. PubMed ID: 24931815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult Post-Kidney Transplant Familial Atypical Hemolytic Uremic Syndrome Successfully Treated With Eculizumab: A Case Report and Literature Review.
    Salameh H; Abu Omar M; Alhariri A; Kisra S; Qasem A; Abdulhak AB
    Am J Ther; 2016; 23(4):e1110-5. PubMed ID: 25486517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D; Naqvi F; Racusen LC; Carter-Monroe N; Montgomery RA; Alachkar N
    Transplantation; 2014 Dec; 98(11):1205-12. PubMed ID: 24933457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When to Stop Eculizumab in Complement-Mediated Thrombotic Microangiopathies.
    Olson SR; Lu E; Sulpizio E; Shatzel JJ; Rueda JF; DeLoughery TG
    Am J Nephrol; 2018; 48(2):96-107. PubMed ID: 30110670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Single Center Experience.
    Alpay N; Ozçelik U
    Transplant Proc; 2019 Sep; 51(7):2295-2297. PubMed ID: 31400975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome.
    Cugno M; Gualtierotti R; Possenti I; Testa S; Tel F; Griffini S; Grovetti E; Tedeschi S; Salardi S; Cresseri D; Messa P; Ardissino G
    J Thromb Haemost; 2014 Sep; 12(9):1440-8. PubMed ID: 24853860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis.
    Legendre CM; Campistol JM; Feldkamp T; Remuzzi G; Kincaid JF; Lommelé Å; Wang J; Weekers LE; Sheerin NS
    Transpl Int; 2017 Dec; 30(12):1275-1283. PubMed ID: 28801959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Hemolytic Uremic Syndrome After Kidney Transplantation: Lessons Learned From the Good, the Bad, and the Ugly. A Case Series With Literature Review.
    Fayek SA; Allam SR; Martinez E; Pan G; Dao A; Rofaiel G
    Transplant Proc; 2020; 52(1):146-152. PubMed ID: 31924403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation in pediatric aHUS within the era of eculizumab therapy.
    Özçakar ZB; Ozaltin F; Gülhan B; Çomak E; Parmaksız G; Baskın E; Topaloğlu R; Kasap Demir B; Canpolat N; Yuruk Yildirim Z; Demircioğlu Kılıç B; Yüksel S; Söylemezoğlu O
    Pediatr Transplant; 2021 May; 25(3):e13914. PubMed ID: 33217100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome.
    van den Brand JA; Verhave JC; Adang EM; Wetzels JF
    Nephrol Dial Transplant; 2017 Jan; 32(suppl_1):i115-i122. PubMed ID: 28391343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living-donor kidney transplantation for atypical haemolytic uremic syndrome with pre-emptive eculizumab use.
    Parikova A; Fronek JP; Viklicky O
    Transpl Int; 2015 Mar; 28(3):366-9. PubMed ID: 25256057
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term remission with eculizumab in atypical haemolytic uraemic syndrome.
    Carter S; Hewitt I; Kausman J
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():7-10. PubMed ID: 28176479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab.
    Choo SZ; Brown F
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():4-6. PubMed ID: 28176471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
    Loirat C; Fakhouri F; Ariceta G; Besbas N; Bitzan M; Bjerre A; Coppo R; Emma F; Johnson S; Karpman D; Landau D; Langman CB; Lapeyraque AL; Licht C; Nester C; Pecoraro C; Riedl M; van de Kar NC; Van de Walle J; Vivarelli M; Frémeaux-Bacchi V;
    Pediatr Nephrol; 2016 Jan; 31(1):15-39. PubMed ID: 25859752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up.
    Okumi M; Omoto K; Unagami K; Ishida H; Tanabe K
    Int Urol Nephrol; 2016 May; 48(5):817-8. PubMed ID: 26865178
    [No Abstract]   [Full Text] [Related]  

  • 19. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N; Ayer M; Ergen A; Ozturk S
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of Eculizumab in atypical hemolytic uremic syndrome after renal transplantation].
    Teixeira CI; Mota RG; Afonso BG; Carneiro TV; Meira GS; Mendonça DU
    J Bras Nefrol; 2015; 37(1):127-30. PubMed ID: 25923760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.